杰成 杰成

Search
1
简体中文 English

杰成医疗

About JC Medical

Help doctors treat illnesses and save people

Check category
[Academic Reprint] Largest sample size! Huaxi Hospital Team Publishes Research Results on TAVR for Aortic Valve Regurgitation
[Academic Reprint] Largest sample size! Huaxi Hospital Team Publishes Research Results on TAVR for Aortic Valve Regurgitation
Aortic regurgitation encompasses a complex array of pathophysiologic mechanisms. According to the literature, the percentage of the general population with severe aortic regurgitation is approximately 1%. The average life expectancy of this group is only about 5 years from the time of diagnosis of the disease. As of today, surgical aortic valve replacement (SAVR) remains the mainstay of treatment for severe aortic regurgitation, while patients at very high risk for surgical procedures or with significant contraindications are usually treated conservatively.
Click to see more
Minimally invasive valve team of Guangdong Provincial People's Hospital successfully completed special and difficult regurgitant TAVR surgery
Minimally invasive valve team of Guangdong Provincial People's Hospital successfully completed special and difficult regurgitant TAVR surgery
Minimally invasive valve team of Guangdong Provincial People's Hospital successfully completed special and difficult regurgitant TAVR surgery
Click to see more
Notice of Conference and Call for Papers | Minimally Invasive China Tour . The 5th Western Valve Forum
Notice of Conference and Call for Papers | Minimally Invasive China Tour . The 5th Western Valve Forum
Notice of Conference and Call for Papers | Minimally Invasive China Tour . The 5th Western Valve Forum
Click to see more
Literature Review｜The application of J-Valve for transapical TAVR is safe and effective
Literature Review｜The application of J-Valve for transapical TAVR is safe and effective
Literature Review｜The application of J-Valve for transapical TAVR is safe and effective
Click to see more
Jebsen Medical was born in Suzhou, rooted in China, and is heading for the world.
Jebsen Medical was born in Suzhou, rooted in China, and is heading for the world.
Jebsen Medical was born in Suzhou, rooted in China, and is heading for the world.
Click to see more
Northwest's first double-gate replacement｜a case of mitral valve intervention valve-in-valve + TAVI surgery
Northwest's first double-gate replacement｜a case of mitral valve intervention valve-in-valve + TAVI surgery
Northwest's first double-gate replacement｜a case of mitral valve intervention valve-in-valve + TAVI surgery
Click to see more
First case in mainland China∣Highly challenging TAVR treatment for right-sided heart with scoliosis
First case in mainland China∣Highly challenging TAVR treatment for right-sided heart with scoliosis
First case in mainland China∣Highly challenging TAVR treatment for right-sided heart with scoliosis
Click to see more
The first fully thoracoscopic tricuspid valve-in-valve operation in China was successfully completed
The first fully thoracoscopic tricuspid valve-in-valve operation in China was successfully completed
The first fully thoracoscopic tricuspid valve-in-valve operation in China was successfully completed
Click to see more
J-Valve China's "Heart" is featured in New York Times Square
J-Valve China's "Heart" is featured in New York Times Square
Click to see more
Review of TAVR Surgery in Guangdong Provincial People's Hospital: J-Valve for Severe Aortic Valve Insufficiency
Review of TAVR Surgery in Guangdong Provincial People's Hospital: J-Valve for Severe Aortic Valve Insufficiency
Click to see more
Green TAVR: Southern Hospital's Cardiac Surgery Team Perfectly Implanted Aortic Valve with Only 15ml of Contrast Agent
Green TAVR: Southern Hospital's Cardiac Surgery Team Perfectly Implanted Aortic Valve with Only 15ml of Contrast Agent
Green TAVR: Southern Hospital's Cardiac Surgery Team Perfectly Implanted Aortic Valve with Only 15ml of Contrast Agent
Click to see more
Domestic TAVR leader Jie Cheng Medical: still leading under heavy pressure
Domestic TAVR leader Jie Cheng Medical: still leading under heavy pressure
Domestic TAVR leader Jie Cheng Medical: still leading under heavy pressure
Click to see more
The first case in the Northwest! TAVR treatment of quadruple leaflet aortic valve insufficiency
The first case in the Northwest! TAVR treatment of quadruple leaflet aortic valve insufficiency
The first case in the Northwest! TAVR treatment of quadruple leaflet aortic valve insufficiency
Click to see more
Same day extubation, eight days discharge | The team of Wang Sheng, the cardiovascular surgery department of Huazhong Fuwai Hospital, has successfully performed the transapical mitral valve replacement independently!
Same day extubation, eight days discharge | The team of Wang Sheng, the cardiovascular surgery department of Huazhong Fuwai Hospital, has successfully performed the transapical mitral valve replacement independently!
Wang Sheng's team in the Cardiovascular Surgery Department of Huazhong Fuwai Hospital has successfully performed transapical mitral valve replacement independently!
Click to see more
Expert Opinion | TAVR Surgical Strategy for Patients with Low Coronary Openings
Expert Opinion | TAVR Surgical Strategy for Patients with Low Coronary Openings
Click to see more
Suzhou Jie Cheng Medical Technology Co., Ltd. interventional artificial biological heart valve products were successfully included in the National Ministry of Science and Technology "Innovative Medical Devices Product Catalog (2018)
Suzhou Jie Cheng Medical Technology Co., Ltd. interventional artificial biological heart valve products were successfully included in the National Ministry of Science and Technology "Innovative Medical Devices Product Catalog (2018)
Suzhou Jie Cheng Medical Technology Co., Ltd. interventional artificial biological heart valve products were successfully included in the National Ministry of Science and Technology "Innovative Medical Devices Product Catalog (2018)
Click to see more
Wang Zhixiong, Director of the Department of Medical Device Registration and Management of the State Drug Administration, visited Jebsen Medical
Wang Zhixiong, Director of the Department of Medical Device Registration and Management of the State Drug Administration, visited Jebsen Medical
Wang Zhixiong, Director of the Department of Medical Device Registration and Management of the State Drug Administration, visited Jebsen Medical
Click to see more
Renji Completes Shanghai's First Post-Marketing Transapical Approach TAVI with a Domestic J-Valve Valve
Renji Completes Shanghai's First Post-Marketing Transapical Approach TAVI with a Domestic J-Valve Valve
Click to see more
China's original new generation of interventional heart valves approved for registration by CFDA
China's original new generation of interventional heart valves approved for registration by CFDA
J-Valve Interventional Prosthetic Heart Valve" developed by Suzhou Jiecheng Medical Technology Co., Ltd. has been approved for marketing by the State Food and Drug Administration. It is the first original and internationally leading interventional heart valve in China, and the only product in the world that can effectively treat aortic valve insufficiency or stenosis.
Click to see more
"I made a right decision" - Canadian "returnee" Zhang Ji praises domestic investment environment
"I made a right decision" - Canadian "returnee" Zhang Ji praises domestic investment environment
Xinhua News Agency, Beijing, March 2 (Xinhua) -- "I made a right decision" -- Canadian "returnee" Zhang Ji praises domestic investment environment
Click to see more
Technology leads the development of modern medical innovation
Technology leads the development of modern medical innovation
Technology leads the development of modern medical innovation
Click to see more
CCTV coverage of innovative medical companies
CCTV coverage of innovative medical companies
CCTV coverage of innovative medical companies
Click to see more
When will 10-minute minimally invasive heart valve surgery come to China?
When will 10-minute minimally invasive heart valve surgery come to China?
(Health Times Reporter Zhengxing Ye) A humanitarian rescue gave a seriously ill elderly woman a new lease of life.
Click to see more
Consul General in Vancouver Liu Fei met with Dr. Zhang Ji, President of Suzhou Jiecheng Medical Technology Co.
Consul General in Vancouver Liu Fei met with Dr. Zhang Ji, President of Suzhou Jiecheng Medical Technology Co.
　　On February 19, 2016, Consul General in Vancouver Liu Fei met with Dr. Zhang Ji, President of Suzhou Jecheng Medical Technology Co.
　　The team led by Dr. Zhang Ji, in cooperation with Dr. Ye Arrow of St. Paul's Hospital in Vancouver, successfully completed the first heart valve replacement surgery using the company's own innovative high-tech product, J-Valve System, and the patient recovered well after the surgery. Dr. Zhang Ji introduced the surgery and the features of the J-Valve System to Consul General Liu, especially emphasizing that this product is an innovative product with all Chinese independent intellectual property rights, which was successfully applied to overseas patients for the first time. This cooperation has opened a new path for China's independent innovative medical devices to go international.
　　Consul General Liu congratulated the positive results of the cooperation between the two sides and expressed his encouragement and support for promoting bilateral scientific and technological cooperation.
Click to see more
Zhang Ji: Contributing to National Science and Technology Exchanges in G20 Countries
Zhang Ji: Contributing to National Science and Technology Exchanges in G20 Countries
In early September, the 11th summit of G20 leaders was held in Hangzhou, Zhejiang Province, and technology cooperation and exchange among G20 countries became the highlight of the internationally anticipated meeting. J-Valve heart valve technology in the medical field is expected to be the representative project of China's science and technology sector for technology exchange among G20 countries, according to the People's Daily Minsheng Weekly.
Click to see more
Focus丨Zhang Ji: Bringing J-Valve valve technology to the world
Focus丨Zhang Ji: Bringing J-Valve valve technology to the world
The 11th G20 Leaders' Summit will be held in Hangzhou, Zhejiang Province in September this year, and technical cooperation and exchange among G20 countries has become an internationally anticipated highlight of the meeting. It is understood that J-Valve heart valve technology in the medical field is expected to be a representative project for technology exchange between China's science and technology sector and G20 countries.
Click to see more
China's "heart tonic" system draws international medical attention
China's "heart tonic" system draws international medical attention
PARIS, May 18 (Xinhua) -- Repairing the heart is one of the challenges that the medical community continues to study. At an international medical conference held in Paris recently, a heart valve replacement system developed in China drew wide attention from the international medical community.
Click to see more

[Academic Reprint] Largest sample size! Huaxi Hospital Team Publishes Research Results on TAVR for Aortic Valve Regurgitation

Aortic regurgitation encompasses a complex array of pathophysiologic mechanisms. According to the literature, the percentage of the general population with severe aortic regurgitation is approximately 1%. The average life expectancy of this group is only about 5 years from the time of diagnosis of the disease. As of today, surgical aortic valve replacement (SAVR) remains the mainstay of treatment for severe aortic regurgitation, while patients at very high risk for surgical procedures or with significant contraindications are usually treated conservatively.
Click to see more
23
2021-04

Minimally invasive valve team of Guangdong Provincial People's Hospital successfully completed special and difficult regurgitant TAVR surgery

Time of issue: : 2021-04--23
Minimally invasive valve team of Guangdong Provincial People's Hospital successfully completed special and difficult regurgitant TAVR surgery
查看详情 查看详情
15
2021-04

Notice of Conference and Call for Papers | Minimally Invasive China Tour . The 5th Western Valve Forum

Time of issue: : 2021-04--15
Notice of Conference and Call for Papers | Minimally Invasive China Tour . The 5th Western Valve Forum
查看详情 查看详情
01
2021-04

Literature Review｜The application of J-Valve for transapical TAVR is safe and effective

Time of issue: : 2021-04--01
Literature Review｜The application of J-Valve for transapical TAVR is safe and effective
查看详情 查看详情
26
2021-03

Jebsen Medical was born in Suzhou, rooted in China, and is heading for the world.

Time of issue: : 2021-03--26
Jebsen Medical was born in Suzhou, rooted in China, and is heading for the world.
查看详情 查看详情
24
2021-03

Northwest's first double-gate replacement｜a case of mitral valve intervention valve-in-valve + TAVI surgery

Time of issue: : 2021-03--24
Northwest's first double-gate replacement｜a case of mitral valve intervention valve-in-valve + TAVI surgery
查看详情 查看详情
18
2021-03

First case in mainland China∣Highly challenging TAVR treatment for right-sided heart with scoliosis

Time of issue: : 2021-03--18
First case in mainland China∣Highly challenging TAVR treatment for right-sided heart with scoliosis
查看详情 查看详情
09
2021-03

The first fully thoracoscopic tricuspid valve-in-valve operation in China was successfully completed

Time of issue: : 2021-03--09
The first fully thoracoscopic tricuspid valve-in-valve operation in China was successfully completed
查看详情 查看详情
Previous page
1
2
…
4
JC Medical

>  About Us

 

 

>  JC Medical Academy

 

 

>  Product Introduction

Contact details

 

+86-512-63036188

Address: C21 Building, 218 Xinghu Street, Suzhou Industrial Park

E-mail：info@jiechengmedical.com

JC Medical

Follow Jiecheng Medical

JC Medical

Follow Genesis 

MedTech